Guardant Health revenue and financials

GH · NASDAQ · USD

$170.69Change from previous close: −8.83%Absolute change: −$16.53

Close · October 6, 2026

In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.

Annual revenue · 2025: $982.02M
  1. $25.25M2016
  2. $49.84M2017
  3. $90.64M2018
  4. $214.38M2019
  5. $286.73M2020
  6. $373.65M2021
  7. $449.54M2022
  8. $563.95M2023
  9. $739.02M2024
  10. $982.02M2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+32.88%
2025 vs 2024
Net margin
-42.4%
2024: -59.0%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets1,9121,9152,0141,2771,3321,3441,4861,5391,6091,7051,7861,797
Current assets1,3651,3681,4668298839271,0551,2271,2901,3091,3471,347
Cash and equivalents1,0539893785805236995265859341,0291,134457
Short-term investments0.01138230.00.0—31434252.5—35.1697
Receivables14413713811613011511088.510184.688.888.8
Inventory10583.985.990.584.177.371.172.367.063.061.977.0
Net property, plant and equipment303304305288296270279270278290303309
Goodwill77.377.377.33.33.33.33.33.33.33.33.33.3
Other intangible assets25.325.525.95.55.96.36.87.37.78.39.09.7
Long-term investments6.56.56.520.116.111.116.111.111.176.5107111
Current liabilities339292303237238226226197202220206227
Accounts payable93.575.054.420.144.849.838.615.542.437.651.777.8
Long-term debt1,5031,5031,5041,1151,1161,1161,1431,1421,1411,1411,1401,139
Total debt1,6971,7051,7101,3261,334———————
Total liabilities2,1352,0962,1131,6311,6371,5951,6251,5991,6111,6361,6281,569
Total equity (incl. minority)-223-181-99.3-354-305-251-140-60.1-1.668.3159228
Retained earnings-3,227-3,107-2,995-2,866-2,773-2,673-2,578-2,467-2,359-2,257-2,142-1,955